- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Lentigo Maligna Melanoma
Total 6865 results
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
Oslo University HospitalActive, not recruitingMalignant MelanomaNorway
-
Ultimovacs ASAActive, not recruitingMalignant MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Medical University of GrazCompleted
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
Immunocore LtdTerminated
-
Genentech, Inc.Completed
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Hoffmann-La RocheCompleted
-
Universitair Ziekenhuis BrusselCompleted
-
Hoffmann-La RocheCompleted
-
Hadassah Medical OrganizationUnknown
-
Merck Sharp & Dohme LLCTerminated
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Australia
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
Genentech, Inc.CompletedMalignant MelanomaUnited States, Australia
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Oslo University HospitalCompleted
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
Yonsei UniversityCompleted
-
SciBase ABCompleted
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
AmpliMed CorporationCompletedMalignant MelanomaUnited States
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted
-
NeoPlas InnovationWithdrawnMelanoma | Malignant MelanomaUnited States
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Northern California Melanoma CenterBayer; Melanoma Research InstituteCompleted
-
Titan PharmaceuticalsTerminated
-
Novo Nordisk A/SCompleted
-
Hoffmann-La RocheWithdrawn
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
NYU Langone HealthCompletedMetastatic Malignant Melanoma
-
MedImmune LLCCompletedMelanoma | Malignant Metastatic MelanomaUnited States
-
National Cancer Institute, NaplesCompletedRecurrent Melanoma | Malignant Melanoma
-
California Cancer Assocaties for Research & ExcellenceUnknownMetastatic Melanoma | Malignant Melanoma of Skin Stage IIIUnited States
-
St. Louis UniversityCompletedMelanoma | Metastatic Melanoma | Stage IV Melanoma | Unresectable Malignant Neoplasm | Stage III MelanomaUnited States
-
Baylor Research InstituteTerminatedMalignant Melanoma Stage IVUnited States
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
ViralyticsCompletedMalignant MelanomaUnited States
-
Ruhr University of BochumCompleted
-
CNAO National Center of Oncological HadrontherapyRecruitingGynecologic Cancer | Malignant MelanomaItaly
-
The Netherlands Cancer Institute4SCActive, not recruiting